Robert M. Gervis, Director at ASPEN AEROGELS INC (ASPN), bought 18,201 shares at $3.99 ($73K) on 2017-04-21, disclosed to the SEC on 2017-04-24.
Scheduled purchase ($73k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.99 | 2,554 | $10K | 14.0% |
| 2 | $3.99 | 2,600 | $10K | 14.3% |
| 3 | $4.00 | 6,336 | $25K | 34.8% |
| 4 | $4.00 | 6,711 | $27K | 36.9% |
| Total | $4.00 avg | 18,201 | $73K | 100% |
| Filing → |
| ASPN | BUY | 2017-05-08 | $3K | — | Filing → |
| ASPN | BUY | 2017-05-04 | $2K | — | Filing → |
| ASPN | BUY | 2017-05-02 | $1K | — | Filing → |